William Blair Investment Management
HZNP

William Blair Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

William Blair Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-162,062
Closed -$18.4M – 424
2022
Q4 		$18.4M Sell
162,062
-1,863,759
-92% -$155M 0.07% 268
2022
Q3 		$125M Buy
2,025,821
+384,278
+23% +$26.9M 0.5% 72
2022
Q2 		$131M Sell
1,641,543
-212,320
-11% -$20.1M 0.49% 74
2022
Q1 		$195M Sell
1,853,863
-477,823
-20% -$46.6M 0.58% 57
2021
Q4 		$251M Sell
2,331,686
-785,682
-25% -$85.7M 0.68% 45
2021
Q3 		$341M Sell
3,117,368
-1,276,319
-29% -$132M 0.96% 16
2021
Q2 		$411M Buy
4,393,687
+244,492
+6% +$22.5M 1.29% 7
2021
Q1 		$382M Sell
4,149,195
-1,104,803
-21% -$93.2M 1.24% 10
2020
Q4 		$384M Sell
5,253,998
-599,224
-10% -$44.5M 1.28% 8
2020
Q3 		$455M Sell
5,853,222
-1,766,356
-23% -$122M 1.77% 3
2020
Q2 		$423M Sell
7,619,578
-700,367
-8% -$30M 1.72% 6
2020
Q1 		$246M Sell
8,319,945
-535,545
-6% -$18.1M 1.2% 12
2019
Q4 		$321M Buy
8,855,490
+515,049
+6% +$15.8M 1.28% 10
2019
Q3 		$227M Buy
8,340,441
+1,382,138
+20% +$35.7M 0.97% 22
2019
Q2 		$167M Buy
6,958,303
+15,946
+0.2% +$404K 0.7% 45
2019
Q1 		$183M Buy
6,942,357
+269,565
+4% +$6.39M 0.77% 39
2018
Q4 		$130M Sell
6,672,792
-3,928,355
-37% -$77M 0.65% 48
2018
Q3 		$208M Buy
10,601,147
+663,821
+7% +$12.6M 0.72% 37
2018
Q2 		$165M Buy
9,937,326
+628,051
+7% +$9.58M 0.61% 48
2018
Q1 		$132M Buy
9,309,275
+483,196
+5% +$7.14M 0.5% 64
2017
Q4 		$129M Buy
8,826,079
+958,414
+12% +$13.5M 0.5% 65
2017
Q3 		$99.8M Buy
7,867,665
+5,883,053
+296% +$74.8M 0.36% 94
2017
Q2 		$23.6M Buy
+1,984,612
New +$24.7M 0.09% 209

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

William Blair Investment Management's HZNP Position: Q1 2023 in Review

William Blair Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 162,062 shares — an estimated $18.4M sold.

William Blair Investment Management first reported a position in HZNP in Q2 2017 and held it in 23 quarters. The position peaked at $455M in Q3 2020. 552 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

  • William Blair Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • William Blair Investment Management sold 162,062 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $18.4M.
  • William Blair Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 23 quarters.
  • William Blair Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $455M in Q3 2020.
  • 552 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on William Blair Investment Management's 13F filing for Q1 2023, filed 12 May 2023.